title: The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis.
abstract: BACKGROUND
  In this study, the results of local injection of platelet-rich plasma (PRP) and corticosteroids in the treatment of plantar fasciitis were compared.
  
  
  METHODS
  Sixty patients who were diagnosed as plantar fasciitis and treated conservatively for at least 3 months and had no response to conservative treatment modalities were involved in this study. The first 30 consecutive patients were treated by local injection of 2 mL of 40 mg Methylprednisolone with 2 mL of 2% prilocaine (metilprednizalone) and the second 30 patients were treated by injecting 3 mL PRP after 2 mL of 2% prilocaine injection. Patients were evaluated according to the modified criteria of the Roles and Maudsley scores and visual analog scale before injection and 3 weeks and 6 months following injection.
  
  
  RESULTS
  The mean VAS heel pain scores measured 6 months after treatment were 3.4 in steroid group and 3.93 in PRP group, and the scores in both groups were significantly lower when compared with pretreatment levels (6.2 in steroid group and 7.33 in PRP group). There was no significant difference between steroid and PRP groups in visual analog scale scores and modified criteria of the Roles and Maudsley scores measured at 3 weeks and 6 months (P > 0.05).
  
  
  CONCLUSIONS
  Our results revealed that both methods were effective and successful in treating plantar fasciitis. When the potential complication of corticosteroid treatment was taken into consideration, PRP injection seems to be safer and at least having same effectivity in the treatment of plantar fasciitis.
authors.affiliation: Ankara Numune Education and Research Hospital, Third Orthopaedics and Traumatology Clinic, 1. Cad 134/3 Bahçelievler, Cankaya, Ankara 06500, Turkey. ertugrul_aksahin@hotmail.com
authors.forename: Ertuğrul
authors.initials: E
authors.lastname: Akşahin
authors.forename: Dağhan
authors.initials: D
authors.lastname: Doğruyol
authors.forename: Halil Yalçın
authors.initials: HY
authors.lastname: Yüksel
authors.forename: Onur
authors.initials: O
authors.lastname: Hapa
authors.forename: Ozgür
authors.initials: O
authors.lastname: Doğan
authors.forename: Levent
authors.initials: L
authors.lastname: Celebi
authors.forename: Ali
authors.initials: A
authors.lastname: Biçimoğlu
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D036981:Fasciitis, Plantar / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D010147:Pain Measurement; D053657:Platelet-Rich Plasma; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D008775:Methylprednisolone